Posts in: September, 2018

Gilead Will Begin Marketing Lower Cost Hepatitis C Drugs in January

Gilead Sciences Inc. announced that it would begin selling generic versions of the company’s two leading treatments for hepatitis C at substantially reduced prices.  The

25 Sep 2018

Hospital Groups File Lawsuit Challenging CMP Rule Delay

Yesterday, four national hospital groups and three hospital systems filed a lawsuit against HHS over the continued delay of the implementation date of the 340B

12 Sep 2018

Hospitals Refile Lawsuit Challenging 2018 OPPS Rule

Yesterday, hospital groups filed a second lawsuit challenging a nearly 30% reduction to Medicare Part B reimbursement for 340B drugs that went into effect January

6 Sep 2018